281 results on '"Vervoort, Stephin J."'
Search Results
2. CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunity
3. Distinct modulation of IFNγ-induced transcription by BET bromodomain and catalytic P300/CBP inhibition in breast cancer
4. Mapping the IMiD‐dependent cereblon interactome using BioID‐proximity labelling.
5. Targeting transcription cycles in cancer
6. PRMT1 acts as a suppressor of MHC-I and anti-tumor immunity
7. Inhibition of pyrimidine biosynthesis targets protein translation in acute myeloid leukemia
8. CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunity
9. Antigen-driven EGR2 expression is required for exhausted CD8+ T cell stability and maintenance
10. Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity
11. Complexity and Diversity of the Mammalian Sialome Revealed by Nidovirus Virolectins.
12. HOIP limits anti-tumor immunity by protecting against combined TNF and IFN-gamma-induced apoptosis
13. SOX4 inhibits oligodendrocyte differentiation of embryonic neural stem cells in vitro by inducing Hes5 expression
14. Tumor immune evasion: insights from CRISPR screens and future directions.
15. Tumor immune evasion: insights from CRISPR screens and future directions
16. C/EBPɑ is crucial determinant of epithelial maintenance by preventing epithelial-to-mesenchymal transition
17. Supplementary Table from Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML
18. Supplementary Table S1 from BET Inhibition Enhances TNF-Mediated Antitumor Immunity
19. Video 1 from BET Inhibition Enhances TNF-Mediated Antitumor Immunity
20. Data from Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML
21. Data from BET Inhibition Enhances TNF-Mediated Antitumor Immunity
22. Video 3 from BET Inhibition Enhances TNF-Mediated Antitumor Immunity
23. Supplementary Figure from Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML
24. Video 2 from BET Inhibition Enhances TNF-Mediated Antitumor Immunity
25. Video 4 from BET Inhibition Enhances TNF-Mediated Antitumor Immunity
26. Supplementary Video Legends and Figures from BET Inhibition Enhances TNF-Mediated Antitumor Immunity
27. Movie 1 from Antagonism of IAPs Enhances CAR T-cell Efficacy
28. Suppllementary Methods and Supplementary Figures 1-5 from BET Inhibition Induces Apoptosis in Aggressive B-Cell Lymphoma via Epigenetic Regulation of BCL-2 Family Members
29. Data from BET Inhibition Induces Apoptosis in Aggressive B-Cell Lymphoma via Epigenetic Regulation of BCL-2 Family Members
30. Data from CDK4/6 Inhibition Promotes Antitumor Immunity through the Induction of T-cell Memory
31. Data from Antagonism of IAPs Enhances CAR T-cell Efficacy
32. Supplementary Figures 1 and 2 from Antagonism of IAPs Enhances CAR T-cell Efficacy
33. TableS1.xlsx from CDK4/6 Inhibition Promotes Antitumor Immunity through the Induction of T-cell Memory
34. Supplementary Data Legends from Antagonism of IAPs Enhances CAR T-cell Efficacy
35. Movie 2 from Antagonism of IAPs Enhances CAR T-cell Efficacy
36. Supplementary Figures from CDK4/6 Inhibition Promotes Antitumor Immunity through the Induction of T-cell Memory
37. Supplementary Information from HDAC Inhibitor Panobinostat Engages Host Innate Immune Defenses to Promote the Tumoricidal Effects of Trastuzumab in HER2+ Tumors
38. Epigenetic changes in inflammatory arthritis monocytes contribute to disease and can be targeted by JAK inhibition
39. Intracellular zinc protects tumours from T cell-mediated cytotoxicity
40. Bcor loss perturbs myeloid differentiation and promotes leukaemogenesis
41. Epigenetic changes in inflammatory arthritis monocytes contribute to disease and can be targeted by JAK inhibition
42. Acetylation of C/EBPε is a prerequisite for terminal neutrophil differentiation
43. RNA decay defines the response to transcriptional perturbation in leukaemia
44. Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML
45. BET Inhibition Enhances TNF-Mediated Antitumor Immunity
46. Targeting transcription cycles in cancer
47. The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancer
48. Antigen-driven EGR2 expression is required for exhausted CD8 + T cell stability and maintenance
49. CDK4/6 Inhibition Promotes Antitumor Immunity through the Induction of T-cell Memory
50. Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.